Marina Pajic

40.1k total citations
64 papers, 2.4k citations indexed

About

Marina Pajic is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Marina Pajic has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 33 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Marina Pajic's work include Pancreatic and Hepatic Oncology Research (28 papers), Cancer Genomics and Diagnostics (13 papers) and Neuroblastoma Research and Treatments (8 papers). Marina Pajic is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Cancer Genomics and Diagnostics (13 papers) and Neuroblastoma Research and Treatments (8 papers). Marina Pajic collaborates with scholars based in Australia, United Kingdom and Netherlands. Marina Pajic's co-authors include Andrew V. Biankin, Paul Timpson, Claire Vennin, Jos Jonkers, Sven Rottenberg, Piet Borst, Adnan Nagrial, Venessa Chin, David K. Chang and Anders O.H. Nygren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Marina Pajic

63 papers receiving 2.3k citations

Peers

Countries citing papers authored by Marina Pajic

Since Specialization

Citations

This map shows the geographic impact of Marina Pajic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Pajic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Pajic more than expected).

Fields of papers citing papers by Marina Pajic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Pajic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Pajic. The network helps show where Marina Pajic may publish in the future.

Co-authorship network of co-authors of Marina Pajic

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Pajic. A scholar is included among the top collaborators of Marina Pajic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Pajic. Marina Pajic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fibroblast Activation Protein Is Overexpressed on Both Stromal and Epithelial Cells Before Pancreatic Ductal Adenocarcinoma: Implications for Early Diagnosis on 68Ga-FAPI-PET/CT 2024 ·Gastroenterology ·William McGahan, (unknown), Liu C, (unknown), Anthony J. Gill, David Cavallucci, Caroline Cooper, (unknown), Shinn Yeung, Thomas Kryza, (unknown), Melissa J. Latter, Nicola Waddell, Jaswinder S. Samra, F. O. Simpson, Marina Pajic, Paul Thomas, Thomas J. O’Rourke, John D. Hooper	4
2	Abstract C017: The anti-fungal itraconazole improves immunotherapy efficacy in pancreatic ductal adenocarcinoma by reversing the immune-suppressive tumor microenvironment 2024 ·Cancer Research ·Sean Porazinski, (unknown), Diego Chacon Fajardo, Howard Chi Ho Yim, Emad El‐Omar, Anthony M. Joshua, Marina Pajic	1
3	CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy 2022 ·Theranostics ·(unknown), Nicholas Lyons, (unknown), (unknown), (unknown), Cameron Snell, Brian Wan-Chi Tse, Kamil A. Sokolowski, Lesley A. Pearce, Timothy E. Adams, Stephen Rose, Simon Puttick, Marina Pajic, Mark N. Adams, Yaowu He, John D. Hooper, Thomas Kryza	6
4	Substrate-biased activity-based probes identify proteases that cleave receptor CDCP1 2021 ·Nature Chemical Biology ·Thomas Kryza, (unknown), S. Lovell, Brittney S. Harrington, Julia Yin, Sean Porazinski, Marina Pajic, Hannu Koistinen, Juha Rantala, Tobias Dreyer, Viktor Magdolen, Ute Reuning, Yaowu He, Edward W. Tate, John D. Hooper	16
5	Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy 2021 ·Frontiers in Oncology ·Laveniya Satgunaseelan, Sean Porazinski, Dario Strbenac, (unknown), Cali E. Willet, Tracy Chew, Rosemarie Sadsad, Carsten E. Palme, Jenny Lee, Michael Boyer, Jean Yang, Jonathan R. Clark, Marina Pajic, Ruta Gupta	18
6	MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma 2019 ·Oncogene ·(unknown), Lesley Castillo, Adelaide I.J. Young, Amanda Mawson, (unknown), Angela Steinmann, (unknown), Ashleigh Parkin, Amber L. Johns, Angela Chou, Andrew M. K. Law, Morghan C. Lucas, Kendelle J. Murphy, Niantao Deng, David Gallego‐Ortega, Catherine E Caldon, Paul Timpson, Marina Pajic, Christopher J. Ormandy, Samantha R. Oakes	16
7	Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth 2018 ·Cancer Research ·Nicola Rath, June Munro, Marie F.A. Cutiongco, (unknown), Nikolaj Gadegaard, Lynn McGarry, Mathieu Unbekandt, Evdokia Michalopoulou, Jurre J. Kamphorst, David Sumpton, Gillian Mackay, Claire Vennin, Marina Pajic, Paul Timpson, Michael F. Olson	57
8	miR-139-5p Modulates Radiotherapy Resistance in Breast Cancer by Repressing Multiple Gene Networks of DNA Repair and ROS Defense 2017 ·Cancer Research ·Marina Pajic, Danielle Froio, Sheridan Daly, (unknown), Ewan K.A. Millar, Peter Graham, Alison Drury, Angela Steinmann, Charles E. de Bock, Alice Boulghourjian, Anaiis Zaratzian, Susan Carroll, Joanne Toohey, Sandra O’Toole, Adrian L. Harris, Francesca M. Buffa, Harriet E. Gee, Georgina E. Hollway, Timothy J. Molloy	110
9	Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice 2017 ·Clinical Cancer Research ·Marina Pajic, Sohvi Blatter, Charlotte Guyader, Maaike Gonggrijp, Ariena Kersbergen, Aslι Küçükosmanoğlu, Wendy Sol, Rinske Drost, Jos Jonkers, Piet Borst, Sven Rottenberg	20
10	The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models 2016 ·Cancer Research ·Lenka Oplustil O’Connor, Stuart L. Rulten, Aaron Cranston, Rajesh Odedra, H. Shelton Brown, Janneke E. Jaspers, (unknown), Charlotte Knights, Bastiaan Evers, Attilla Ting, Robert H. Bradbury, Marina Pajic, Sven Rottenberg, Jos Jonkers, (unknown), Niall M.B. Martin, Keith W. Caldecott, Alan Lau, Mark J. O’Connor	60
11	Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling 2016 ·Molecular & Cellular Proteomics ·Emily S. Humphrey, Shih‐Ping Su, Adnan Nagrial, Falko Hochgräfe, Marina Pajic, Gillian M. Lehrbach, Robert G. Parton, Alpha S. Yap, Lisa G. Horvath, David K. Chang, Andrew V. Biankin, Jianmin Wu, Roger J. Daly	26
12	Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma 2014 ·Clinical Cancer Research ·Fares Al‐Ejeh, Marina Pajic, Wei Shi, Murugan Kalimutho, Mariska Miranda, Adnan Nagrial, Angela Chou, Andrew V. Biankin, Sean M. Grimmond, (unknown), Michael P. Brown, Kum Kum Khanna	31
13	SOX9 regulates ERBB signalling in pancreatic cancer development 2014 ·Gut ·Adrien Grimont, Andreia V. Pinho, Mark J. Cowley, (unknown), Amanda Mawson, Marc Giry-Laterrière, Géraldine Van Den Steen, Nicola Waddell, Marina Pajic, Christine Sempoux, Jianmin Wu, Sean M. Grimmond, Andrew V. Biankin, Frédéric P. Lemaigre, Ilse Rooman, Patrick Jacquemin	67
14	Returning individual research results for genome sequences of pancreatic cancer 2014 ·Genome Medicine ·Amber L. Johns, David K. Miller, Skye H. Simpson, Anthony J. Gill, Karin S. Kassahn, Jeremy L. Humphris, Jaswinder S. Samra, Katherine Tucker, Lesley Andrews, David K. Chang, Nicola Waddell, Marina Pajic, (unknown), John V. Pearson, Sean M. Grimmond, Andrew V. Biankin, Nikolajs Zeps	14
15	Peer relationships and the biomedical doctorate: a key component of the contemporary learning environment 2013 ·Journal of Higher Education Policy and Management ·Matthew W. Kemp, Timothy J. Molloy, Marina Pajic, Elaine Chapman	8
16	Adjuvant chemotherapy in elderly patients with pancreatic cancer 2013 ·British Journal of Cancer ·(unknown), Adnan Nagrial, David K. Chang, Nam Q. Nguyen, Amber L. Johns, Lorraine A. Chantrill, Jeremy L. Humphris, Venessa Chin, Jaswinder S. Samra, Anthony J. Gill, Marina Pajic, Mark Pinese, Emily K. Colvin, Christopher J. Scarlett, Angela Chou, James G. Kench, R. L. Sutherland, Lisa G. Horvath, Andrew V. Biankin	52
17	Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan 2010 ·Cancer Research ·Serge A.L. Zander, Ariena Kersbergen, Eline van der Burg, (unknown), Olaf van Tellingen, (unknown), Janneke E. Jaspers, Marina Pajic, Anders O.H. Nygren, Jos Jonkers, Piet Borst, Sven Rottenberg	66
18	Small-Molecule Multidrug Resistance–Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma 2009 ·Cancer Research ·Catherine A. Burkhart, Fujiko Watt, Jayne Murray, Marina Pajic, Anatoly Prokvolit, Chengyuan Xue, Claudia L. Flemming, Janice Smith, Andrei A. Purmal, (unknown), Pavel G. Komarov, Katerina V. Gurova, Alan C. Sartorelli, Glenn M. Marshall, Murray D. Norris, Andrei V. Gudkov, Michelle Haber	84
19	Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer 2009 ·Cancer Research ·Marina Pajic, Jayasree K. Iyer, Ariena Kersbergen, Eline van der Burg, Anders O.H. Nygren, Jos Jonkers, Piet Borst, Sven Rottenberg	77
20	Reversan, a novel inhibitor of MRP1, increases the therapeutic index of conventional chemotherapeutic agents 2008 ·Cancer Research ·Catherine A. Burkhart, Jayne Murray, (unknown), Marina Pajic, Fujiko Watt, Claudia L. Flemming, Janice Smith, Katerina V. Gurova, Glenn M. Marshall, Murray D. Norris, Andrei V. Gudkov, Michelle Haber	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact